Wedbush Securities’s Syndax Pharmaceuticals SNDX Stock Holding History

Wedbush Securities’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Buy	+9,054	New	+$197K	0.01%	1099
2025 Q1	–	Sell	-10,000	Closed	-$132K	–	1181
2024 Q4	$132K	Hold	10,000	–	–	﹤0.01%	1069
2024 Q3	$193K	Hold	10,000	–	–	0.01%	1006
2024 Q2	$205K	Hold	10,000	–	–	0.01%	1070
2024 Q1	$238K	Hold	10,000	–	–	0.01%	997
2023 Q4	$216K	Hold	10,000	–	–	0.01%	926
2023 Q3	$145K	Hold	10,000	–	–	0.01%	964
2023 Q2	$209K	Hold	10,000	–	–	0.01%	916
2023 Q1	$211K	Hold	10,000	–	–	0.01%	917
2022 Q4	$255K	Hold	10,000	–	–	0.01%	800
2022 Q3	$240K	Hold	10,000	–	–	0.01%	815
2022 Q2	$192K	Hold	10,000	–	–	0.01%	937
2022 Q1	$174K	Hold	10,000	–	–	0.01%	1008
2021 Q4	$219K	Hold	10,000	–	–	0.01%	1025
2021 Q3	$191K	Hold	10,000	–	–	0.01%	1076
2021 Q2	$172K	Hold	10,000	–	–	0.01%	1082
2021 Q1	$224K	Buy	+10,000	New	+$226K	0.01%	938

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wedbush Securities's SNDX Position: Q1 2026 in Review

Wedbush Securities opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 9,054 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #1099 among its holdings. This is a return to the name: Wedbush Securities previously reported a position in SNDX as recently as Q4 2024.

Wedbush Securities first reported a position in SNDX in Q1 2021 and has held it in 17 quarters since. The position peaked at $255K in Q4 2022. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

Wedbush Securities held 9,054 shares of Syndax Pharmaceuticals worth $212K as of Q1 2026.
Syndax Pharmaceuticals was a new Wedbush Securities position in Q1 2026.
Syndax Pharmaceuticals made up 0.01% of Wedbush Securities's portfolio in Q1 2026, its #1099 holding.
Wedbush Securities first reported a position in Syndax Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
Wedbush Securities's Syndax Pharmaceuticals position peaked at $255K in Q4 2022.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.